Ehave Provides Progress Update on its HPPD Study with University of Melbourne
February 02, 2023 08:30 ET
|
Ehave
MIAMI, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the "Company"), a Healthcare Analytics provider with interests in the psychedelic and mental health sectors, is pleased to...
Israel-Based Clearmind Medicine Announces First Clinical Center to Join Its Clinical Trial for Alcohol Use Disorder
December 28, 2022 09:00 ET
|
Clearmind Medicine Inc.
Company engaged a leading clinical center in Israel and intends to conduct its first- in- human trial in the United States as well Tel Aviv, Israel / Vancouver, Canada, Dec. 28, 2022 (GLOBE...
FDA Grants Ehave Consent to Proceed With Its Clinical Study on Intravenous Ketamine Infusion for Major Depressive Disorder
December 15, 2022 08:00 ET
|
Ehave
MIAMI, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a Healthcare Analytics provider with interests in the psychedelic and mental health sectors, announced today...
The Addition of Three Mental Health Clinics to Irwin Naturals' Florida Footprint Solidifies the Companies Impact as One of the Fastest-Growing Chains of Mental Health Clinics
December 09, 2022 07:30 ET
|
Irwin Naturals
LOS ANGELES, Dec. 09, 2022 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) completed the acquisition of the assets of Clare Clinic, Inc., d/b/a...
Irwin Naturals Agrees to Add Idaho Clinic to Its National Chain of Psychedelic Mental-Health Clinics
October 04, 2022 07:00 ET
|
Irwin Naturals
LOS ANGELES, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) has reached a binding agreement on September 30, 2022 to acquire...
Clearmind Applies for Patent to Treat Obesity and Metabolic Syndrome
September 22, 2022 08:30 ET
|
Clearmind Medicine Inc.
Patent Application, Based on Research at the Hebrew University, is Latest Result of Ongoing Collaboration with SciSparc Ltd. VANCOUVER, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine...
Irwin Naturals Emergence Adds New England Clinic to Its National Footprint
August 15, 2022 07:30 ET
|
Irwin Naturals
LOS ANGELES, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) completed the acquisition of its first Vermont clinic, continuing...
Irwin Naturals Emergence Making Immediate Impact in New England
July 28, 2022 10:25 ET
|
Irwin Naturals
LOS ANGELES, July 28, 2022 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) completed the acquisition of the assets of New England Ketamine,...
Irwin Naturals Files Q1 2022 Financials
May 30, 2022 09:23 ET
|
Irwin Naturals
Cannabis Licensing and Ketamine ClinicRollup Strategy Accelerating Growth Company to host conference call Tuesday, May 31, 2022 at 2:00 pm EST LOS ANGELES, May 30, 2022 (GLOBE NEWSWIRE) -- Irwin...
Europe’s Leading Psychedelic Conference Returns to Amsterdam
May 26, 2022 09:00 ET
|
OPEN Foundation
AMSTERDAM, May 26, 2022 (GLOBE NEWSWIRE) -- The OPEN Foundation, a European non-profit organisation dedicated to advancing psychedelic research and the responsible integration of psychedelics into...